Rosy  Wills

Rosy Wills

Followers 0
Following 0
According to market research report Weight Loss Management Market to grow from USD 175.94 billion in 2017 to USD 245.51 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1152The growth of this market is majorly attributed to the growing rate of obesity, increasing prevalence of lifestyle diseases, and increasing number of bariatric surgeries.Based on diet, the weight loss and weight management market is segmented into meals, beverages, and supplements.In 2017, the beverages segment is expected to account for the largest share of the weight loss and weight management market.Growth in this segment is majorly driven by the growing diabetic population across the globe.By equipment, the weight loss management market is segmented into fitness equipment and surgical equipment.The fitness equipment segment is estimated to register the highest growth rate during the forecast period.The high growth in this segment can primarily be attributed to the continuous technological advancements in fitness equipment and growing accessibility to gyms.Based on service, the weight loss and weight management market is further segmented into fitness centers, slimming centers, consulting services, and online weight loss programs.The service segment is expected to grow at the highest CAGR during the forecast period.In 2017, North America is expected to dominate the global weight loss management market primarily due to factors such as the increasing incidence of obesity and chronic diseases, rising awareness about nutrition and healthy lifestyles, and growing number of fitness centers in the region.
According to the market research report Liquid Biopsy Market is expected to reach $2,047.9 Million by 2022 from an estimated $715.7 Million in 2017, at a CAGR of 23.4%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350Some of the key factors driving the growth of this market include increasing preference for noninvasive procedures, increasing prevalence of cancer and availability of funding for liquid biopsy RThe key players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).By clinical application, the therapy selection segment is expected to account fors the largest market share in 2017.Based on clinical application, the liquid biopsy market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring.The therapy selection segment is expected to account for the largest share of the liquid biopsy devices market in 2017.This is due to the ability of therapy selection to detect advanced-stage cancers (stage III and IV), followed by increasing studies on liquid biopsy and advancements made in this field to also aid in detection of early-stage cancers.By application, the cancer segment is expected to account for the largest market share in 2017.Based on application, the market is segmented into cancer and non-cancer applications (which includes reproductive health and organ transplant diagnostics).In 2017, cancer applications segment is expected to account for the largest share of the liquid biopsy market.By circulating biomarkers, circulating tumor cells is expected to account for the largest market share in 2017.
According to market research report the Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392The growth of the global Hemostasis Analyzer Market is largely driven by the increasing prevalence of cardiovascular diseases and blood disorders, technological advancements in coagulation analyzers, and the rising geriatric population.Emerging economies and growing number of reagent rental agreements are expected to offer growth opportunities to market players in the coming years.Clinical laboratory analyzers dominated the Coagulation Analyzer Market in 2019Based on product, the Hemostasis Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers.In 2019, the clinical laboratory analyzers segment accounted for a larger share of the market.The large share of this segment can be attributed to factors such as the growing prevalence of blood disorders and increasing development of automated coagulation systems with faster turnaround times, compact size, and expanded capabilities.Optical technology segment accounted for the largest share of the Coagulation Analyzer Market, by technology, in 2019The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology.However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies.The most widely used technology in the Hemostasis Analyzer Market is the optical technology.
According to research report the global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4%Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52426876The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population, and rising focus on cost containment in healthcare delivery are driving the greater uptake of mobile technologies.The Patches product segment accounted for the largest share of the Medical Wearable market in 2019Based on product type, the patches segment accounted for the largest share of the Clinical Wearable Market in 2019.The large share of this segment can be there have been significant technological advancements in medical wearable devices, which have helped improve the treatment outcomes for patients.Growing use of high-tech devices that are compact, user-friendly, and come with a better graphical user interface for easy visibility of resulted data are helping to increase the market penetration of clinical-grade wearables.These wearables are playing an integral role in treating and monitoring various medical conditions in patients and driving better health outcomes.The vital sign monitoring device segment accounted for the largest share of the Clinical-Grade Wearable market in 2019Based on device type, the vital sign monitoring segment accounted for the largest share of the Clinical Wearable Market in 2019.Population aging is poised to become one of the most significant social transformations of the twenty-first century, with implications for nearly all sectors of society, including labor and financial markets, the demand for goods and services, such as housing, transportation and social protection, as well as family structures and intergenerational ties.The Long-term care centers, nursing homes, and assisted-living facilities segment accounted for the largest share and highest growth of the Clinical-Grade Wearable market in 2019Based on the Clinical grade wearables market by end-user, the end-user is segmented into Long-term Care Centers/ Assisted Living Facilities/Nursing Homes, Hospitals, Ambulatory Care Centers, and Home/Patients.In 2019, the Long-term Care Centers/ Assisted Living Facilities/Nursing Homes accounted for the largest share and highest growth of the Medical Wearable market.
According to the new market research report Artificial Intelligence In Genomics Market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market.However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.Based on offering, the Artificial Intelligence In Genomics Market is segmented into software and services.The software and services segment accounted for largest share of the global AI in genomics market in 2019.Software is needed to generate new insights from large-scale datasets and help understand genomic variations, thus enhancing the search for disease-causing variants and reducing clinical analysis times.The benefits offered by AI in software are driving its adoption among end users.Based on functionality, the AI in genomics market is segmented into genome sequencing, gene editing, clinical workflows, and predictive genetic testing & preventive medicine.
According to the new market research report Ambulatory EHR Market is expected to reach USD 6.8 billion by 2025 from USD 5.2 billion in 2020, at a CAGR of 5.7% during the forecast period of 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235617627The key factors propelling the growth of the global ambulatory EHR market are government support for the adoption of HCIT, an increase in the COVID-19 patient volume, growing usage of EHR solutions, and the need to curtail healthcare costs.On the other hand, heavy infrastructure investments and the high cost of deployment are limiting the growth of the global market to a certain extent.The prominent players operating in the ambulatory EHR market are Epic Systems Corporation (US), Cerner Corporation (US), Allscripts Healthcare Solutions (US), Medical Information Technology, Inc. (MEDITECH, US), CPSI (US), NextGen Healthcare Information Systems, LLC (US), eClinicalWorks (US), athenahealth, Inc. (US), Modernizing Medicine, Inc. (US), Medical Transcription Billing Corporation (MTBC, US), Amazing Charts, LLC (US), Greenway Health (US), eMDs, Inc. (US), NetSmart Technologies (US), and CureMD (US).The cloud-based solutions segment is projected to occupy the majority of the market share during the forecast period.Based on delivery mode, the hospital EHR market is segmented into on-premise and cloud-based solutions.In 2019, the cloud-based solutions segment accounted for the largest share of the market.The market is mainly driven by the advantages associated with cloud-based solutions, which include flexibility and cost reductions in healthcare delivery.Practice management application is the largest application segment in the marketOn the basis of application, the global market has been segmented into practice management, patient management, e-prescribing, referral management, population health management, decision support, and health analytics.The practice management segment commanded the largest share of the global ambulatory EHR market in 2019.The significant share of this application segment can primarily be attributed to the wide range of advantages associated with practice management solutions, including increased efficiency of day-to-day operations, enhanced value of services provided to patients, and improved adherence to compliance requirements.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235617627In 2019, North America accounted for the largest share of the market.The ambulatory EHR market is predominantly divided into five major geographies, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
According to the new market research report Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods.Moreover, rising R investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), Creative Diagnostics (US), Synbiosis (UK), Bioanalyse (Turkey), ZHUHAI DL BIOTECH Co., Ltd. (China), Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (US), Merck KGaA (US), Hi-Media Laboratories (India), Liofilchem S.r.l.(Italy), ELITechGroup (France), Mast Group Ltd. (UK), CONDALAB (Spain), Genefluidics, Inc. (US), Biotron Ltd (Australia), InvivoGen (US), MP Biomedicals (US), QuantaMatrix Inc. (South Korea), and PML Microbiologicals Inc. (US), among others are some of the major players operating in the global Antimicrobial Susceptibility Testing Market.The susceptibility testing disks subsegment of manual antimicrobial susceptibility testing products to hold major market share by 2025Based on the product, the antimicrobial susceptibility testing market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables.Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019.The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries.Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).Based on type, the antibacterial susceptibility testing systems segment is expected to account for the largest share of the AST Market in 2019Based on type, the antibacterial susceptibility testing systems market has been segmented into the antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing, and susceptibility testing types.
According to the new market research report Tangential Flow Filtration Market is expected to grow from USD 944 million in 2019 to USD 1,590 million by 2024 at a CAGR of 11.0% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72081607Market growth is largely driven by factors such as increasing adoption of single-use technologies, advantages of tangential flow filtration over normal flow filtration and increased cGMP adoption.Based on material type, the global tangential flow filtration market is divided into PES/PS, regenerated cellulose, and other materials.The PES/PS segment is expected to account for the largest share of the global TFF market in 2019.The hydrophilic nature of PES/PS, its low protein-binding properties, and wide range of applications, such as ultrafiltration of downstream processing, product concentration, and the filtration of biological and pharmaceutical solutions, is expected to drive the demand for this material.Tangential flow filtration systems segment to account for the largest share of the global TFF Market in 2019Based on the product, the TFF System Market is segmented into systems, membrane filters, and accessories.The systems segment is expected to account for the largest share of the market in 2019, owing to factors such as the increasing use of different single-use systems among end users due to their advantages, such as a reduced need for product validation and cleaning.Bioprocess applications projected to account for the largest application segment of the market in 2019Based on application, the market is segmented into bioprocess applications, viral vector and vaccine purification, and other applications such as drug formulation, blood plasma fractionation, media and buffer preparation, and pharmaceutical water purification.The bioprocess applications segment is expected to dominate the market in 2019 owing to factors such as growth in the overall biopharmaceutical industry, increasing biologics research, and significant growth in biologics research funding.The major companies in the global TFF Market are Merck Millipore (US), Danaher Corporation (US), Sartorius AG (Germany), GE Healthcare (US), and Repligen Corporation (US).Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=72081607North America is projected to account for the largest share of the Tangential Flow Filtration Market in 2019In 2019, North America is expected to account for the largest share of the TFF System Market, followed by Europe.The largest share of the North American market is attributed to the presence of a well-established biopharmaceutical industry and significant R spending by pharmaceutical and biotechnology companies.
According to research report the clinical alarm management market is expected to reach $1,724 million by 2023 from an estimated $457 million in 2018, at a CAGR of 30.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69939577Based on component, the global clinical alarm management market is segmented into two broad categories based on component, namely— solutions and services.The services segment is expected to grow at the highest CAGR during the forecast period owing to the increasing adoption of clinical alarm management solutions and indispensable and recurring nature of services.Based on product, the global clinical alarm management market is categorized into nurse call systems, physiological monitors, EMR integration systems, bed alarms, ventilators, and others (infusion pumps and pulse oximeters).The EMR integration systems segment is also expected to grow at the highest rate during the forecast period owing to the increased adoption of EHRs and other interoperability solutions in healthcare organizations, growing regulatory requirements & healthcare reforms, shift of point-of-care diagnostics from hospitals to home care settings, and the need for integrated healthcare systems to improve the quality and outcome of healthcare systems.The major players in the clinical alarm management market include Koninklijke Philips (Netherlands), Vocera Communications (US), Mobile Heartbeat (US), GE Healthcare (US), Ascom Holdings (Switzerland), Spok, Inc. (US), Bernoulli Enterprise (US), Connexall (Canada), Capsule Technologie (US), and Masimo Corporation (US).These players have adopted various growth strategies, such as product launches and enhancements; acquisitions; expansions; and agreements, partnerships, mergers, and collaborations.Product launches and partnerships and have been the most dominating strategy adopted by major players of clinical alarm software market from 2015 to 2018, which helped them to innovate on their offerings and broaden their customer base.Recent Developments -• In October 2017, GE Healthcare (US) entered into partnership with Ascom (Switzerland) to enable the addition of alarm management solution called Digistat Patient Watch to GE Healthcare’s portfolio of solutions for the intensive care.• In August 2017, Ascom (Switzerland) partnered with Dräger (Germany) to deliver clinical alarm management solutions to healthcare providers.• In October 2016, Vocera Communications (US) acquired Extension Healthcare (US).This was expected to enable Vocera add Extension Healthcare’s complementary software to Vocera’s Communication Platform and expand customer relationships and grow software revenue faster by providing highly relevant cross-selling opportunities.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=69939577North America is estimated to account for the largest share of the clinical alarm software market in 2018.
According to the new market research report Ambulatory EHR Market is expected to reach USD 6.8 billion by 2025 from USD 5.2 billion in 2020, at a CAGR of 5.7% during the forecast period of 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235617627The key factors propelling the growth of the global ambulatory EHR market are government support for the adoption of HCIT, an increase in the COVID-19 patient volume, growing usage of EHR solutions, and the need to curtail healthcare costs.On the other hand, heavy infrastructure investments and the high cost of deployment are limiting the growth of the global market to a certain extentThe cloud-based solutions segment is projected to occupy the majority of the market share during the forecast period.Based on delivery mode, the hospital EHR market is segmented into on-premise and cloud-based solutions.In 2019, the cloud-based solutions segment accounted for the largest share of the market.The market is mainly driven by the advantages associated with cloud-based solutions, which include flexibility and cost reductions in healthcare delivery.Practice management application is the largest application segment in the marketOn the basis of application, the global market has been segmented into practice management, patient management, e-prescribing, referral management, population health management, decision support, and health analytics.The practice management segment commanded the largest share of the global ambulatory EHR market in 2019.The significant share of this application segment can primarily be attributed to the wide range of advantages associated with practice management solutions, including increased efficiency of day-to-day operations, enhanced value of services provided to patients, and improved adherence to compliance requirements.In 2019, North America accounted for the largest share of the market.The ambulatory EHR market is predominantly divided into five major geographies, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
According to research report the Contrast Media Contrast Agent Market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911Growth in the market can primarily be attributed to the rising volume of CT and MRI examinations globally, and the rapidly growing cancer and CVD population across the globe, increasing number of approvals of contrast agents.Rising research activities on contrast agents & their applications are the key areas of opportunity in this marketGE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the Contrast Media Contrast Agent Market.Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B.Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).Recent Developments:> In 2017, GE Healthcare (US) launched a new Macrocyclic MRI contrast agent, Clariscan, in Europe.> In 2019, Bayer AG (Germany) received FDA approval for Gadavist as the first contrast agent for cardiac MRI.> In 2019, Guerbet Group partnered with IBM Watson Health for AI in medical imaging to support liver cancer diagnostics, utilizing CT and MRI imaging.Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media.In 2019, the iodinated contrast media segment is estimated to account for the largest share of the contrast media industry.The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.Based on modality, the contrast agent market is segmented into X-ray/CT, MRI, and ultrasound procedures.
According to research report the medical device contract manufacturing market is projected to reach USD 91.3 billion in 2024 from an estimated USD 55.0 billion by 2024, at a CAGR of 10.6% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851Factors such as increasing automation in the manufacturing of medical devices and advanced technologies integrating electronics and medical devices are expected to drive the growth of the medical device outsourcing market.The increased connectivity and data-gathering capabilities of these technologies make it possible to build high-volume, regulation-compliant manufacturing processes with efficient inventory and production management.With the increasing adoption of Industry 4.0 technologies in manufacturing critical and sophisticated medical devices, the medical device contract manufacturing market is expected to grow significantly during the forecast period.Class II medical devices are estimated to hold the largest share of the medical device outsourcing market in 2019Class II medical devices are expected to account for a major share of the market in 2019, followed by Class I and Class III devices, respectively.The large share of this segment can be attributed to the large number of medical devices that fall under this device class and fewer regulatory compliance necessities than Class III devices.The IVD devices segment is expected to account for the largest share of the medical device contract manufacturing market in 2019In 2019, the IVD devices segment is likely to account for the largest share of the medical device outsourcing market.The share of this segment can be attributed to the increasing volume of IVD tests performed globally, a growing number of hospitals and clinical laboratories in developing countries, automation and technological advancements in instruments with high-throughput capabilities, and advances in life science research.By service type, the device development and manufacturing services segment is estimated to account for the largest share of this market in 2019In 2019, the device development and manufacturing services segment is expected to account for the largest share of the global medical device outsourcing market.The increasing adoption of contract manufacturing services by OEMs in the medical device industry, growing consumption of medical devices, and the improving capabilities for device development and manufacturing are the major factors responsible for the large share of the device development and manufacturing services segment.APAC is expected to dominate the market in 2019APAC is estimated to account for the largest share of the medical device outsourcing market in 2019, followed by North America.
According to the new market research report Life Science Analytics Market is expected to reach 42.0 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 13.7% during the forecast period of 2020 to 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653Growth in this life science analytics software market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales & marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, growing pressure to curb healthcare spending, and the need for improved patient outcomes.On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent.Based on application, the life science analytics market is segmented into research & development (clinical trials and preclinical trials), sales & marketing, regulatory compliance, supply chain optimization, and pharmacovigilance.The sales & marketing segment is expected to grow at the highest CAGR during the forecast period.Based on type, the pharmaceutical life science analytics market is segmented into descriptive analytics, predictive analytics, and prescriptive analytics.The descriptive analytics segment accounted for the largest share of the Life Science Analytics Market in 2019.The large share of this segment is attributed to the significant usage of descriptive analytics by stakeholders to gain a better understanding of the past trends and events occurring in real-time.Based on the delivery mode, the Pharmaceutical Life Science Analytics Market is segmented into the on-demand model and the on-premise model.The on-demand model segment is expected to grow at the highest CAGR during the forecast period, owing to advantages such as increasing demand for self-driven analytics, lack of upfront capital investments for hardware, extreme capacity flexibility, and pay-as-you-go pricing of this model.In 2019, North America accounted for the largest market share, followed by Europe.
According to market research report Weight Loss Management Market to grow from USD 175.94 billion in 2017 to USD 245.51 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1152The growth of this market is majorly attributed to the growing rate of obesity, increasing prevalence of lifestyle diseases, and increasing number of bariatric surgeries.Beverages segment to dominate the market in 2017Based on diet, the weight loss and weight management market is segmented into meals, beverages, and supplements.In 2017, the beverages segment is expected to account for the largest share of the weight loss and weight management market.Growth in this segment is majorly driven by the growing diabetic population across the globe.The fitness equipment segment is projected to grow at the highest CAGR during the forecast period.By equipment, the weight loss management market is segmented into fitness equipment and surgical equipment.The fitness equipment segment is estimated to register the highest growth rate during the forecast period.The high growth in this segment can primarily be attributed to the continuous technological advancements in fitness equipment and growing accessibility to gyms.North America to dominate the weight loss and weight management marketIn 2017, North America is expected to dominate the global weight loss management market primarily due to factors such as the increasing incidence of obesity and chronic diseases, rising awareness about nutrition and healthy lifestyles, and growing number of fitness centers in the region.In 2017, Europe is expected to account for the second-largest share of this market.
According to the new market research report Hyperspectral Imaging Market is projected to reach USD 30.0 billion by 2025 from USD 12.4 billion in 2020, at a CAGR of 19.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343The Snapshot technology segment is expected to grow at the highest CAGR during the forecast periodBased on technology, the Hyperspectral Imaging Systems Market is segmented into pushbroom (line-scanning), snapshot (single shot), and other technologies [whiskbroom (point-scanning), tunable filters (wavelength scan), and imaging FTIR (time scanning)].The pushbroom segment is estimated to account for the largest share of the market in 2019, while the snapshot segment is projected to register the highest CAGR during the forecast period.This can be attributed to the advantages offered by snapshot hyperspectral imaging systems, which make this technology most suitable for real-time analysis.PERSONALIZE THIS RESEARCH> Triangulate with your Own Data> Get Data as per your Format and Definition> Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor> Any level of PersonalizationIn 2019, the cameras segment accounted for the largest share of the marketOn the basis of product, the Hyperspectral Imaging Market is segmented into cameras and accessories.Cameras are expected to command the larger share of the market, by product, in 2019.Technological advancements, the development of affordable hyperspectral imaging cameras, and the increasing adoption of hyperspectral technology for defense and industrial applications are driving the growth of the hyperspectral cameras segment.The prominent players operating in the Hyperspectral Imaging Market include Headwall Photonics, Inc. (US), Applied Spectral Imaging, Inc. (US), Corning Incorporated (US), Surface Optics Corporation (US), Norsk Elektro Optikk AS (Norway), Resonon, Inc. (US), Specim, Spectral Imaging Ltd. (Finland), Telops, Inc. (Canada), BaySpec, Inc. (US), Cubert GmbH (Germany), inno-spec GmbH (Germany), XIMEA GmbH (Germany), imec (Belgium), and ChemImage Corporation (US).Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=246979343North America was the largest regional market for market in 2019The global Hyperspectral Imaging Market has been divided into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).North America is expected to account for the largest share of the global market in 2019.
According to the new market research report the Oral Care Market is projected to reach USD 53.3 billion by 2025 from USD 45.8 billion in 2020, at a CAGR of 3.1%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246The Factors such as the rising awareness about oral hygiene, growing incidence of dental diseases, and technological advancements in oral care products are expected to drive the growth of the Oral Care Market.Increasing the online purchase of oral care products is expected to create new growth opportunities for players operating in this market.Based on product, the market is categorized into toothpaste, toothbrushes & accessories, mouthwashes/rinses, denture products, dental accessories/ancillaries, and dental prosthesis cleaning solutions.In 2019, the toothpaste segment was expected to account for the largest share of the Oral hygiene Market.The large share of this segment can primarily be attributed to the enormous adoption of toothpaste for maintaining oral hygiene, the treatment of dental caries, and its use in post-surgical procedures.By distribution channel, the Oral Hygiene Market is segmented into consumer stores, retail pharmacies, dental dispensaries, and online distribution.Online distribution is expected to grow at the fastest CAGR in the forecast period in this segment.This high growth can be attributed to the increase in the number of e-commerce platforms focused on oral care/oral hygiene products, better convenience and availability of a variety of products through this channel along with proper discounts.In 2019, the Asia Pacific was estimated to account for the largest share of the Oral hygiene Market, followed by Europe.
1
According to the new market research report Healthcare Integration Market is projected to reach USD 6.0 billion by 2025 from USD 3.5 billion in 2020, at a CAGR of 11.4% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=228536178The increasing need for integration primarily drives the market for healthcare IT integration solutions as a result of the rising healthcare costs and the growing volume of data generated in healthcare systems.The need to improve patient safety and favorable government and private support for HCIT will also contribute to market growth in the coming years.However, the high cost of HCIT integration is limiting the overall adoption of these solutions.The prominent players in this Healthcare Integration Market are Infor (US), InterSystems Corporation (US), Cerner Corporation (US), Orion Health (New Zealand), NextGen Healthcare Inc. (US), iNTERFACEWARE, Inc. (Canada), Allscripts Healthcare Solutions, Inc. (US), Epic Systems Corporation (US), GE Healthcare (US), IBM (US), Oracle Corporation (US), Capsule Technologies, Inc. (US), Koninklijke Philips (Netherlands), AVI-SPL, Inc. (US), Corepoint Health (US), and MEDITECH (US).The services segment is expected to for the largest share of the Healthcare IT Integration Market in 2019.Based on product & service, the market is categorized mainly into products and services.In 2019, the services segment was expected to account for the largest share of the Healthcare IT Integration Solutions Market.The large share of this segment can primarily be attributed to its indispensable nature.In addition to this, the rising need for simplifying workflows in healthcare organizations; the increasing demand for data standardization; and the growing need to build, design, and implement standardized, interoperable networking platforms are also driving the demand for healthcare IT integration services.By end user, the hospital segment is expected to grow at the highest CAGR during the forecast period.Based on end-user, the Healthcare IT Integration Solutions Market is segmented into hospitals, laboratories, clinics, diagnostic imaging centers, and other end users.
According to the new market research report the remote patient monitoring market is projected to reach USD 117.1 billion by 2025 from USD 23.2 billion in 2020, at a CAGR of 38.2% between 2020 and 2025.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77155492The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, advancements in telecommunications, benefits of RPM to reduce the burden on medical resources, growing incidences of chronic diseases, and increasing investments in telehealth and RPM are the major factors driving the growth of this market.However, the regulatory variations across regions, healthcare fraud, and informal usage of social media practices is expected to restrain the market growth during the forecast period.Some of the prominent players in the remote patient monitoring market are BioTelemetry Inc. (US), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers AG Germany, OMRON Healthcare (Japan), Boston Scientific Corporation (US), Abbott Laboratories (US), Resideo Life Care Solutions (US), Vivify Health, Inc. (US), ALTEN Calsoft Labs (France), Preventice Solutions (US), Bio-Beat Technologies (Israel), VitalConnect (US), Welch Allyn (US), Teladoc Health Inc. (US), Dexcom Inc. (US), iRhythm Technologies, Inc. (US), and VivaLNK Inc. (US).Based on end users, the global remote patient monitoring market is broadly segmented into providers, payers, patients, and other end users.The providers segment accounted for the largest share of the global market in 2019.This can be attributed to the increased adoption of remote monitoring in chronically ill and old aged patients, advancements in RPM monitoring devices, and the increasing number of RPM services offered by providers.Based on the product, the market is segmented into software & services and devices.The software and services segment accounted for the largest share of the global market in 2019.The large share of this segment is mainly due to the increasing reimbursement for RPM programs and the rising number of chronic illnesses, thus leading to the growing adoption of RPM services across the globe.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=77155492In 2019, North America accounted for the largest share of the market, followed by Europe.
According to research report the cancer biomarkers market to reach USD 20.4 billion by 2022. and is estimated to grow at a CAGR of 12.2% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202The increasing prevalence of cancer, rising government support for research on cancer biomarkers, growing use of biomarkers in drug discovery and development, and increasing use of biomarker tests for diagnostic purposes are the major factors that are driving the growth of this market.The genetic biomarkers segment is expected to grow at the highest CAGR during the forecast periodBased on biomarker type, the market is segmented into genetic biomarkers, protein biomarkers, and other biomarkers (cell, viral, and carbohydrate biomarkers).During the forecast period, the genetic biomarkers segment is estimated to grow at the highest CAGR majorly due to advancements in high-throughput technologies, such as next-generation sequencing, which have enhanced the speed and accuracy of genetic biomarker discovery and diagnosis.The breast cancer segment accounted for the largest share of the cancer biomarkers market in 2016Based on cancer type, the market is segmented into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-Hodgkins lymphoma, kidney, and other cancers (such as cervical, multiple myeloma, CNS, gastric, liver, pancreatic, oral cavity and pharynx, stomach, and ovarian cancers).The breast cancer segment accounted for the largest share of this market owing to the high and growing prevalence of breast cancer, increasing awareness about breast cancer, rising number of breast cancer screening programs, and growing research on breast cancer.The major players operating in the cancer biomarkers market are Abbott (US), Affymetrix (US), Roche (Switzerland), Illumina (US), QIAGEN (Netherlands), Agilent (US), Thermo Fisher (US), Merck (US), Becton Dickinson and Company (US), and Hologic (US).Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=202North America accounted for the largest share of the cancer biomarkers market in 2017, followed by Europe.Growth in the developed markets of North America and Europe is primarily driven by the high adoption of advanced technologies like NGS, increasing number of research studies for the discovery and development of novel biomarkers, presence of a large number of pharmaceutical companies, rising funding and investments from public and private organizations, and increasing use of biomarkers in patient stratification and drug development process.Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected]
According to the new market research report "Dental Equipments Market by Product (Dental Imaging Equipment (Panoramic, Sensor, Camera), Lasers, Diode Lasers, Dental Chairs, CAD/CAM, Handpieces, Dental Units, Casting Machines) & End User ( Laboratories, Hospitals, Clinics) - Global Forecast to 2026", published by MarketsandMarkets™, the Dental Equipment Market is estimated to reach USD 6.2 billion in 2021 and is projected to reach USD 8.9 billion by 2026, at a CAGR of 7.7% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=784Due to the increasing prevalence of oral health disorders, sedentary and changing lifestyles, growing consumer awareness, and rising dental tourism.An increasing number of dental laboratories investing in CAD/CAM technologies will provide abundant opportunities.However, the high cost of dental imaging systems and lack of reimbursement for dental procedures are expected to restrain the growth of this market during the forecast period.The therapeutic dental equipment segment accounted for the largest share of dental equipment market in 2020Based on products, the dental equipment market is broadly segmented into therapeutic and diagnostic dental equipment.The therapeutic dental equipment segment is categorized into dental operatory & treatment center equipment, general equipment, and dental lasers.The diagnostic dental equipment segment includes extraoral imaging systems, intraoral imaging systems, and dental imaging software.The dental equipment market has been growing steadily throughout the years due to factors such as the rapidly growing aging population and the increasing incidence of dental disorders and diseases.Dental hospitals & clinics segment accounted for the largest share of dental equipment market in 2020.Based on the end user, the dental equipment market is segmented into hospitals & clinics, academic & research institutes, and other end users.The large market share is attributed to the increasing number of dental clinics and hospitals across the globe, rapid adoption of advanced technologies, increasing dental tourism in emerging markets, and the rising number of group dental practices in developed countries.Asia Pacific is expected to witness the fastest growth during the forecast period of 2021–2026.Geographically, the dental equipment market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
1
More

Top